Elizabeth Kutter, vice president and deputy general counsel, MHA, joined Paul W. Smith for a WJR Spotlight interview April 9 about the value the federal 340B Drug Pricing Program brings to Michigan communities.
The conversation explored how hospitals use 340B savings to reinvest directly into patient care by maintaining or expanding services, lowering out-of-pocket costs and supporting community health initiatives.
The segment also addressed ongoing pressure from drug manufacturers to enact policy changes that would weaken the program through restrictions that would impact healthcare access, especially in rural communities. Kutter emphasized how the program operates at no cost to taxpayers and allows hospitals to stretch limited resources as drug, labor and supply costs continue to rise.
Members with questions regarding media requests should contact Elise Gonzales at the MHA.